View in EDS HTML Full Text PDF Full Text

Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.

Saved in:
Bibliographic Details
Title: Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.
Authors: Parkinson CJ; School of Biomedical Sciences, Charles Sturt University, Orange, Australia., Birrell GW; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Chavchich M; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Mackenzie D; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Haynes RK; Centre for Excellence in Pharmaceutical Discovery, North-West University, Potchefstroom, South Africa., de Kock C; Division of Pharmacology, University of Cape Town, Observatory, South Africa., Richardson DR; Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, The University of Sydney, Sydney, Australia., Edstein MD; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 2965-2973.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31325302
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Parkinson+CJ%22">Parkinson CJ</searchLink>; School of Biomedical Sciences, Charles Sturt University, Orange, Australia.<br /><searchLink fieldCode="AU" term="%22Birrell+GW%22">Birrell GW</searchLink>; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Chavchich+M%22">Chavchich M</searchLink>; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Mackenzie+D%22">Mackenzie D</searchLink>; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Haynes+RK%22">Haynes RK</searchLink>; Centre for Excellence in Pharmaceutical Discovery, North-West University, Potchefstroom, South Africa.<br /><searchLink fieldCode="AU" term="%22de+Kock+C%22">de Kock C</searchLink>; Division of Pharmacology, University of Cape Town, Observatory, South Africa.<br /><searchLink fieldCode="AU" term="%22Richardson+DR%22">Richardson DR</searchLink>; Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Edstein+MD%22">Edstein MD</searchLink>; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227513617%22">The Journal of antimicrobial chemotherapy</searchLink> [J Antimicrob Chemother] 2019 Oct 01; Vol. 74 (10), pp. 2965-2973.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7513617 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057453%22">03057453 </searchLink><i>NLM ISO Abbreviation: </i>J Antimicrob Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31325302
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jac/dkz290
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2965
    Titles:
      – TitleFull: Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parkinson CJ
      – PersonEntity:
          Name:
            NameFull: Birrell GW
      – PersonEntity:
          Name:
            NameFull: Chavchich M
      – PersonEntity:
          Name:
            NameFull: Mackenzie D
      – PersonEntity:
          Name:
            NameFull: Haynes RK
      – PersonEntity:
          Name:
            NameFull: de Kock C
      – PersonEntity:
          Name:
            NameFull: Richardson DR
      – PersonEntity:
          Name:
            NameFull: Edstein MD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2019 Oct 01
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2091
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: The Journal of antimicrobial chemotherapy
              Type: main
ResultId 1